Gateway 2012: Allegheny Bradford Corporation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Allegheny Bradford Corporation


Allegheny Bradford Corporation
www.alleghenybradford.com
11 Lincoln Drive
Lewis Run, PA 16738
William Waytenick - General Sales Manager sales@alleghenybradford.com, wwaytenick@alleghenybradford.com

Description of Company:

Manufacturers and fabricators of the highest quality heat transfer, filter housing, tanks, pressure vessels, process systems and custom fabrication in stainless steel and high nickel alloys for the pharmaceutical and biotechnical industries for end users and OEM's.

The Allegheny Bradford Corporation started in 1962 manufacturing stainless steel equipment. Our 50 years of experience has taught us to put our customer’s needs first. Our reputation of precision engineered equipment sets the standard for quality and performance. Unsurpassed documentation set ABC apart from its competitors and is the best in the industry. We are dedicated to our customers and are with them every step of the way.

Booth Invitation:

Allegheny Bradford Corporation is pleased to announce that we are exhibiting at INTERPHEX 2012. The INTERPHEX show is May 1–3 at Jacob K. Javitz Convention Center, New York, NY. Please stop by and visit us at booth 2645 .

Automated Sampling Systems – Our sampling/POU systems can support manual to fully automated Sampling, CIP and SIP of the fluid lines.

Stainless Steel Tanks – All stainless steel pressure tanks and vessels are custom made.

PDFs & Links:
ABC Shell & Tube Heat Exchangers
ABC Filter Housings
Stainless Steel Tanks
Modular Process Systems
How2Media announces that Allegheny Bradford Corporation will be a part of its "World's Greatest!" series

 

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search

Click here